Free Trial

Oscar Health (NYSE:OSCR) Shares Gap Down - Here's Why

Oscar Health logo with Finance background

Key Points

  • Oscar Health's shares gapped down from $18.73 to $17.84 before market opening, last trading at $17.57 with significant volume of 6,488,543 shares.
  • Several analysts have downgraded Oscar Health's stock ratings, with Wells Fargo slashing its price target from $16.00 to $10.00 and UBS lowering theirs to $11.00.
  • Despite a 29% year-over-year revenue increase to $2.86 billion, Oscar Health reported a loss of ($0.89) earnings per share, slightly outperforming analyst estimates of ($0.90).
  • MarketBeat previews the top five stocks to own by October 1st.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $18.73, but opened at $17.84. Oscar Health shares last traded at $17.57, with a volume of 6,488,543 shares.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on OSCR shares. Wells Fargo & Company cut shares of Oscar Health from an "equal weight" rating to an "underweight" rating and decreased their price target for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Robert W. Baird reissued a "neutral" rating and issued a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. UBS Group reissued a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Finally, Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Four analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, Oscar Health presently has an average rating of "Strong Sell" and a consensus price target of $12.07.

Get Our Latest Research Report on Oscar Health

Oscar Health Stock Performance

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The stock has a 50-day simple moving average of $15.96 and a 200-day simple moving average of $15.18. The stock has a market cap of $4.69 billion, a P/E ratio of -22.40 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. During the same quarter in the previous year, the business posted $0.20 earnings per share. The business's revenue for the quarter was up 29.0% on a year-over-year basis. Research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of OSCR. BNP Paribas Financial Markets acquired a new position in Oscar Health in the fourth quarter valued at approximately $590,000. Cetera Investment Advisers lifted its stake in Oscar Health by 17.1% in the fourth quarter. Cetera Investment Advisers now owns 27,066 shares of the company's stock valued at $364,000 after buying an additional 3,961 shares during the period. Deutsche Bank AG increased its holdings in shares of Oscar Health by 51.2% during the fourth quarter. Deutsche Bank AG now owns 172,127 shares of the company's stock valued at $2,313,000 after acquiring an additional 58,282 shares in the last quarter. Focus Partners Wealth bought a new stake in shares of Oscar Health during the fourth quarter valued at approximately $729,000. Finally, Nuveen Asset Management LLC increased its holdings in shares of Oscar Health by 1.0% during the fourth quarter. Nuveen Asset Management LLC now owns 2,356,298 shares of the company's stock valued at $31,669,000 after acquiring an additional 23,237 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.